1	3 female subject without childbearing potential two year post-menopausal bilateral oophorectomy or tubal ligation complete hysterectomy be eligible female subject of childbearing potential must be non-pregnant non-lactating and abide by one of the following medically acceptable contraceptive measure|contraceptive[279,292]||||||||||64078|64078|contraceptive
2	oral contraceptive pill contraceptive injection implant or patch intrauterine device in place for at least three month vasectomise partner or abstinence throughout the study and for one month after discontinuation of study medication when the contraceptive pill be use this should contain no less than|oral contraceptive pill[301,324]||||||||||2821|2821|oral contraceptive
2	oral contraceptive pill contraceptive injection implant or patch intrauterine device in place for at least three month vasectomise partner or abstinence throughout the study and for one month after discontinuation of study medication when the contraceptive pill be use this should contain no less than|contraceptive[325,338]||||||||||64078|64078|contraceptive
2	oral contraceptive pill contraceptive injection implant or patch intrauterine device in place for at least three month vasectomise partner or abstinence throughout the study and for one month after discontinuation of study medication when the contraceptive pill be use this should contain no less than|contraceptive[301,324]||patch[360,365]|||||three month[408,419]|||64078|64078|contraceptive
2	oral contraceptive pill contraceptive injection implant or patch intrauterine device in place for at least three month vasectomise partner or abstinence throughout the study and for one month after discontinuation of study medication when the contraceptive pill be use this should contain no less than|contraceptive[544,557]||pill[558,562]|||||one month[483,492]|||64078|64078|contraceptive
3	50 ?g oestrogen|oestrogen[609,618]||||||||||4100|4100|estrogens
